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Introduction
left ventricular hypertrophy (lVh) is an adaptive response 
to increased hemodynamic load that myocardium undergoes 
during postnatal maturation, characterized by the enlargement 
of individual cardiomyocytes, without cell division. Although 
this process is initially compensatory, findings from the 
Framingham studies have provided evidence that the presence 
of lVh is an independent risk factor for the development of 
heart failure (15). Aspects of developmental hypertrophy 
are reemployed in the adult heart in response to diverse 
pathophysiologic stimuli such as hypertension, ischemic 
heart disease, valvular insufficiency, and cardiomyopathy 
(20). Previous studies have demonstrated that lVh is not a 
sole adaptive response to an increased workload because other 
biological changes play an important role in this process (9, 
10) such as alterations in gene expression, including induction 
of the expression of immediate early genes (e.g., c-myc 
and c-fos), embryonic genes [e.g., atria1 natriuretic factor 
(AnF)], and other genes (e.g., transforming growth factor-p) 
that regulate cell growth and differentiation. however, the 
molecules that mediate the growth of cardiomyocytes during 
lVh remain unknown.
observations have suggested that cell cycle control 
molecules, such as tumor suppressor proteins (8, 25, 28) may 
be implicated in this process. Regulation of the cell cycle in the 
cardiac muscle is unique. Most adult cardiomyocytes are highly 
differentiated and little DnA synthesis or cell proliferation 
occurs in myocardium. But upon hormonal or mechanical 
stimulation significant DNA synthesis can be elicited and 
progression of cardiomyocytes into S phase can occur (5). 
it is known, however, that regulation of cell growth and 
differentiation involves stimulatory and inhibitory pathways of 
cell cycle progression (21). Several lines of evidence suggest 
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The relation between myocardial structural and functional changes and p53 proteins during the development of left ventricular 
hypertrophy (LVH) has not yet been reported. The purpose of this study was to determine whether p53 protein expression is 
altered during development of LVH, induced by pressure overload.
LVH was induced in 80 male Wistar adult rats by abdominal aortic banding (AAB) and was monitored at the 10th, 15th, 20th, 
25th, 35th and 45th post-operation days by echocardiography and validated by postmortem examination. Sham operated (SO) rats 
(n=60) went the same operation without banding. The expression of p53 protein in the nuclear and cytoplasmic extracts from left 
ventricular tissue from AAB and SO rats were analyzed by immunoblotting at each of the pointed days.
Relative to SO, echo-left ventricular mass-to-tibia length (LVM/TL) ratio in AAB increased progressively on the 10th and the 15th 
day. On the 20th day we observed a short lasting regression of LVH, followed by a new marked increase on the 25th and 35th day; 
then there was presented a plateau. Relative to SO the changes in LV%FS (77% ± 2.2 %) in AAB rats remained at the same level 
throughout the studied period without significant differences in body weight or tibia length (TL). Results from echocardiography 
were validated by necropsy. Echo LVM/TL correlated significantly with actual heart weight-to-tibia length ratio (r=0.69, P< 
0.0001, n=140).
The level of p53 protein expression in the nuclear extracts from LV tissues obtained from AAB rats increased significantly by 
77%, 78%, 35% and 63% at day 10th, 20th, 35th and 45th, respectively compared with SO, and returned to SO levels by day 15th 
and 25th post-operation. The highest level of p53 protein in the nuclear extracts from LV tissues obtained from AAB rats was 
determined on 20th day concomitant with significant reduction of the actual heart mass in the group with AAB rats, compared 
with the same groups on the other days. In the cytozol the expression of p53 was always higher in the SO, compared with AAB 
groups. Furthermore, the level of p53 protein in the nuclear extracts from AAB rats significantly correlated with the actual heart 
weight during the studied period (r= -0.59, P< 0.0001, n=60).
Following the development of LVH over a relatively long period of time and providing the changes in short intervals, it was found 
a short lasting regression during ongoing pressure overload concomitant with significantly increased expression of p53 protein 
in the nuclear extracts from AAB rats.
This study adds new important concepts for the time dependency of LVH and suggests that p53 protein may modulate the 
adaptive growth of pressure overload induced LVH.
978 Biotechnol. & Biotechnol. eq. 22/2008/4
that p53 is a critical component of an inhibitory pathway that 
negatively regulates progression of the cell cycle (24) and 
prevents the cells from entering S phase. p53 plays multiple 
roles in cells. A wide range of stress factors can activate p53 to 
elicit adaptive responses that include, but that are by no means 
restricted to, growth arrest and apoptosis. these properties 
are profoundly influenced by cell type and tissue-specific 
modifiers, which are of great importance but remain poorly 
understood (12).
evidence in vitro suggests a functional association between 
cardiomyocyte stretch and p53 activation (17). in several in 
vivo injury models (ie, myocardial infarction (22), reperfusion 
injury (30), pacing-induced heart failure (3), and isoproterenol-
induced hypertrophy (18) cardiac p53 expression is known to 
increase. nevertheless, our current knowledge of the expression 
of protein p53 during the development of lVh induced by 
pressure overload remains unclear.
With the use of abdominal aortic banding (AAB) - a simple 
technique for inducing lVh in rats, the aim of this study was to 
examine by immunoblotting the effect of pressure overload on 
the expression of protein p53 in left ventricular (lV) tissues. 
our data suggest that protein p53 may be involved in the 




experiments were performed with male Wistar rats, 200±10 
g body weight and 9-10 weeks old at the beginning of the 
experiment. All procedures were performed in accordance with 
the ethical committee note of the Medical University Plovdiv 
(Bulgaria) for care and use of laboratory animals.
Animal model 
Surgical Induction of Pressure Overload
Pressure overload was produced by AAB subdiaphragmatically 
as previously described (27). Briefly, under anesthesia with 
pentobarbital sodium (65mg/kg ip) intraperitoneally and a 
midline abdominal laparotomy, a nearly 1 cm segment of 
abdominal aorta was separated free just bellow the diaphragma 
and a needle, having 0.95 mm external diameter was placed 
on the top of the aorta. A 2-0 surgical silk was tightly banded 
around the needle and aorta providing a uniform degree 
of constriction. the needle was then carefully withdrawn 
from the ligature so that the diameter of the constriction 
approximated that of the needle. Muscles and skin were closed 
layer by layer with 3-0 silk suture. For sham operated (So) 
animals the identical procedure was performed except AAB. 
Postoperatively, all animals were fed commercial rat chow and 
had free access to water. On the final day of the study each rat 
with AAB was examined to verify the constriction.
echocardiographic study
After sedation with pentobarbital sodium (65mg/kg) injected 
intraperitoneally, rats were secured in a supine position, shaved 
at the precordium, and transthoracic echocardiography was 
performed by using Sono Site 180 (SonoSite inc., USA) equipped 
with a 10 Mhz linear transducer.
the heart was imaged in the 2-D mode in the parasternal 
long-axis view. From this view, an M-mode cursor was 
positioned perpendicular to the interventricular septum 
and posterior wall of the left ventricular at the level of the 
papillary muscles. left ventricular anterior wall thickness 
(AWt), posterior wall thickness (PWt), left ventricular end-
diastolic diameter (lVeDD), and left ventricular end-systolic 
diameter (lVeSD) were measured. All measurements were 
done from leading edge to leading edge according to the 
American Society of echocardiography guidelines (26). three 
representative cardiac cycles were analyzed and averaged for 
each measurement. left ventricular mass (lVM) was calculated 
by use of the following formula, assuming a spherical left 
ventricular geometry and validated in rats (19): lVM (g) = 
1.04 x [(lVeDD+ PWt+ AWt)3-lVeDD3], where 1.04 is 
the specific gravity of myocardium. The percentage of LV 
fractional shortening (lV%FS) was calculated as [(lVeDD 
lVeSD)/lVeDD] × 100.
hemodynamic measurements
Mean blood pressure (MBP) was measured in anesthetized 
(pentobarbital sodium - 65mg/kg ip) rats (n=5 from each 
group and at each time point). For this purpose the left carotid 
artery was cannulated with a fluid-filled polyethylene (PE-50) 
catheter connected to a pressure transducer (Еxperimetria, Ltd, 
hungary) in-line to cardiostar co-100 polygraph (cardiostar 
CO-100, Еxperimetria MM, Ltd., Budapest, hungary).
cytoplasmic and nuclear protein extraction.
cytoplasmic and nuclear extracts were prepared from 
snap-frozen lV tissue (14). the lV tissue (100 mg) was 
homogenized, using a DiAX900 P/n595 homogenizer in 
300µl an ice-cold phosphate-buffered saline (PBS) containing 
5µl protease inhibitor cocktail (AeBSF 104mM, Aprotinin 
0.08mM, leupeptin 2mM, Bestatin 4mM, Pepstatin A 1.5mM, 
e-64 1.4mM - Sigma). homogenate was centrifuged for 10 min 
at 12000g at 4°c. the supernatant was kept as cytoplasmic 
extract and stored at -80°c. For preparation of nuclear extracts, 
pelleted nuclei were resuspended in PBS, centrifuged, and 
further lysed for 15 min on ice in PBS and Triton Х-100 added 
to a final concentration of 0.5% in the presence of a cocktail of 
protease inhibitors as described above. After centrifugation at 
12000g at 4°c for 10 min the supernatant was transferred to a 
new tube as nuclear extract and stored at -80°c until needed. 
Protein concentrations in each sample were determined 
according to the method of Bradford (4) using bovine serum 
albumin (BSA) as a standard.
Immunoblotting
Samples (45 µg of protein) were heat-denatured in laemmli 
sample buffer (10% glycerol, 5% b-mercaptoethanol, 2% 
sodium dodecyl sulphate (SDS), 62.5mM tris (ph 6.8), 0.05% 
bromphenol blue, final concentrations) and after centrifugation 
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loaded onto a 12% SDS-PAGe gel. After electrophoresis, 
proteins were transferred to a nitrocellulose membrane. 
Membranes with transferred proteins were incubated for 1 h 
in blocking solution containing 5% nonfat milk in phosphate-
buffered saline-0.2% tween 20 (PBSt), and then overnight 
with primary mouse monoclonal antibody to p53 (1:500; Santa 
cruz Biotechnology, inc.; Pab 240) in blocking solution at 4°c. 
After being washed with PBSt, membranes were incubated 
with goat anti-mouse igG peroxidase-conjugated secondary 
antibody (Jackson immunoResearch lab inc) diluted 1:4000 
for 1h at room temperature. Bound antibody was detected 
as chemiluminescence, using ecl reagents (Amersham 
Biosciences, UK). The signals were quantified by measuring 
the optical density with an image analyzer (Gel-Pro Analyzer 
3.1). each protein sample was analyzed three times, and at least 
nine different samples from Ac and So rats were examined at 
each time point after operation.
experimental protocol
After the initial assessment by using echocardiography rats 
were randomly divided into 2 groups and subjected to AAB or 
sham operation.
in 10-16 AAB- rats and 10 So- rats transthoracic 
echocardiography was performed at 10th day, 15th day, 20th 
day, 25th day, 35th day and 45th day after surgery and on the 
appointed day they were euthanized.
Body weight (BW) was recorded for each rat, both on 
the day of operation and on the day of death. on the last day, 
after all measurements were completed, each animal chest 
was opened through a left thoracotomy, the pericardium was 
exposed, and the heart was quickly removed, immersed in ice-
cold PBS and weighed. left ventricular free wall was separated 
and each sample of lV tissue was used for protein preparation. 
left ventricular tissue was frozen immediately in liquid 
nitrogen and stored at -70°c until required for biochemical 
analysis. the length of the tibia was measured. the right tibia 
was dissected, and its length from the condyles to the tip of the 
medial malleolus was measured with a micrometer caliper by 
the method of Yin et al. (29).
statistical analysis
Values are expressed as means ± standard deviation. Serial 
echocardiographic studies were tested by repeated measures 
ANOVA followed by Fisher’s protectedleast significant 
difference test. Results obtained in postmortem examination, 
in echocardiographic studies and protein levels were analyzed 
with analysis of variance of the multivariate profiles for 
dependent groups (MAnoVA), followed by the Duncan 
post hoc test to assess differences between groups (AAB and 
So), as well as the effect of aortic banding in time. A value 
of P<0.05 was considered statistically significant. The relation 
between variables of echo-lVM, actual hW and protein levels 
were examined by regression analysis.
results and discussion
mortality
A total of 155 rats were initially enrolled in this study – 95 
underwent AAB and 60 rats - So. Upon surgery, the death rate 
for AAB was nearly 16% - mainly in the first 12 hours after the 
operation and only two died on the third day. there were no 
fatalities in So.
hemodynamic measurements
the time course for alterations in MBP and heart rate after 10, 
15, 20, 25, 35 and 45 days of pressure overload is presented 
in table 1. Relative to So MBP was increased by 53 mmhg 
in AAB rats at each time point after pressure overload. no 
significant difference was observed in heart rate (HR) between 
AAB and So rats and within each group across time. Body 
weight (BW) and tibia length (tl) were analyzed across groups 
and in time. There was significant increase in BW and TL with 
time in rats from both groups, with no significant difference 
between the groups at each time point (table 1).
echocardiographic measurements
in vivo 2-D guided M-mode echocardiograms were obtained 
on the 10th, 15th, 20th, 25th, 35th and 45th day after operation in 
all rats. echo-lVM was calculated and results were expressed 
as the ratio of echo lVM-to-tl. in relation to So, echo lVM-
to-TL ratio in AAB rats increased significantly (e.g., by 24% 
tABle 1
Measurements of body weight (BW), tibia length (tl), mean blood pressure (MBP), heart rate (hR) in sham-operated (So) and 










so AAB so AAB so AAB so AAB
10th d 197±9 197±18 34.9±0.6 34.7±1.4 111±3 165±5# 403±15 372±16
15th d 211±9 219±11 35.8±0.7 35.9±0.8 112±3 167±6# 410±11 399±17
20th d 223±9 228±15 36.5±0.7 36.4±0.6 113±3 166±4# 409±8 409±13
25th d 244±9 253±30 36.8±0.4 36.7±1.0 113±5 164±2# 410±7 405±17
35th d 260±7 283±19 37.5±0.5 38.1±0.8 113±2 165±3# 410±7 406±17
45th d 290±14 301±20 38.4±0.5 38.5±0.8 114±4 168±4# 409±8 402±16
Data are means±SD; # - P<0.05 AAB vs. respective So. d-day.
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at day 10, 51% at day 15, 21% at day 20, 45% at day 25, 69% 
at day 35 and 70% at day 45 (fig. 1A). interestingly, a short-
lasting regression of lVh at day 20 was observed. on this 
exact day echo LVM-to-TL ratio was significantly lesser in 
respect to the other time points in AAB group (e.g. by 16% to 
10th day, by 27% to 15th day, by 28% to 25th day, by 49% to both 
35th and 45th days).
All echocardiographic parameters remained with 
no significant changes in SO during the studied period. 
echocardiographic data showed that hearts of the rats subjected 
to AAB maintained normal lV chamber size and systolic 
function. Relative to So the changes in lV%FS (77% ± 2.2 %) 
in AAB rats were not statistically significant and remained at 
the same level throughout the studied period (fig. 1c).
necropsy validation
the time dependency of lVh and the short lasting regression 
of the hypertrophy on the 20th day were verified by necropsy 
at each time point. Actual heart weight (hW) was measured at 
each time point and results expressed as the ratio of hW-to-tl 
(fig. 1B). they supported the observed by echocardiographic 
study changes in the development of lVh. Furthermore, echo 
LVM-to-TL ratio correlated significantly with HW-to-TL ratio 
(r=0.69; P<0.0001) (fig. 1d).
changes in p53 protein expression after AAB and so 
operation
to determine the expression of p53 protein during the 
development of lVh, nuclear and cytoplasmic extracts from lV 
tissue of AAB and So rats were analyzed by immunoblotting. 
We measured the level of p53 protein in cytoplasmic and 
nuclear extracts of lV tissues from AAB and So rats at days 
10th, 15th, 20th, 25th, 35th and 45th after operation. equal protein 
loading in each experiment was confirmed by Coomassie blue 
staining of the gels and by reprobing each membrane with a 
mouse monoclonal antibody to α-actin.
Each experiment was repeated twice to confirm the 
reproducibility of the results. A representative experiment is 
shown in fig. 2. lV tissue obtained from So rats showed a 
constant level of p53 protein in the nuclear and cytoplasmic 
extracts throughout the day 10-45 postoperative period. 
Relative to the nuclear extracts from the lV tissue obtained 
from So rats at each time point, the protein levels of p53 
detected in the cytoplasmic extracts from the same samples 
were significantly higher.
the level of p53 protein in the cytoplasmic extracts from 
AAB rats was higher on 15th and 25th days (0.39±0.05 and 
0.38±0.09 respectively) compared with AAB rats on the other 
days (10th -0.33±0.08, 20th -0.34±0.09, 35th - 0.34±0.08 and 45th 
fig. 1. time-course changes in (A) echocardiographically derived left ventricular mass ventricular –to-tibia length ratio [echo-lVM/tl], (B) actual heart weight 
to tibia length ratio [hW/tl], (c) percentage of lV fractional shortening (lV%FS) assessed by echocardiography of 10-16 abdominal aortic banding rats (AAB) 
and 10 sham-operated (So). (d) correlation between actual heart weight-to-tibia length ratio [hW/tl] and echo-lV mass-to tibia length ratio [echo-lVM/tl]; 
r =0.69, P<0.0001; n=140. d - day; Data are means±SD; a - P<0.05 vs. 10 day AAB; b - P<0.05 vs. 15 day AAB; c - P<0.05 vs. 20 day AAB; d - P<0.05 vs 25 
day AAB; e - P<0.05 vs 35 day AAB; f - P<0.05 vs 45 day AAB; #- P<0.05 vs respective So.
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-0.17±0.09), such that no significant differences was observed 
between the cytoplasmic levels of p53 protein in AAB and So 
rats at 15th and 25th days (fig. 3A).
fig. 2. immunoblotting analysis to show the expression of p53 protein in 
cytoplasmic and nuclear extracts from lV tissue obtained from rats after 
abdominal aortic banding (AAB) and sham operated (So). Membranes were 
probed with antibodies to p53 and α-actin (to confirm equal protein loading in 
each experiment). the position of molecular weight markers is indicated to the 
left of the Western blots.
interestingly, the level of p53 protein in the nuclear 
extracts from lV tissues obtained from AAB rats increased 
significantly by 77%, 78%, 35% and 63% at day 10th, 20th, 35th 
and 45th respectively, compared with So, and returned to So 
levels by day 15th and 25th post operation (fig. 3B). however, 
the highest level of p53 protein in the nuclear extracts from 
lV tissues obtained from AAB rats was noted on the 20th day 
concomitant with significant reduction of the actual heart mass 
in the group with AAB rats, compared with the same groups 
on the other days. As shown in fig. 3c the level of p53 protein 
in the nuclear extracts from AAB rats significantly correlates 
with the actual heart weight for the studied period (r= -0.59, 
P< 0.0001).
figure 2 also shows that the changes in p53 protein level 
in AAB rats was not due to variations in the amount of protein 
loaded as each membrane was reprobed with an antibody 
to α actin and showed a band at 42 kDa, for which the level 
altered very little in samples from both AAB and So groups 
throughout the studied period.
the changes in the expression of p53 protein from nuclear 
and cytoplasmic extracts from lV tissue of AAB and So rats 
at each time point were quantified by measuring the optical 
densities of the bands obtained from 9-13 separate hearts with 
two determinations per tissue sample. p53 protein expression 
was normalized individually to the level of expression of 
the total cytoplasmic and nuclear protein for each sample 
respectively (fig. 3A and B).
in this study we report the subcellular expression of one 
of the main modulator of the cell cycle protein p53 during the 
development of lVh. Recent studies have proved that despite 
the diminishing ability of the cardiac myocyte to undergo cell 
division, in some instances, cardiac myocyte nuclear division 
can be re-initiated in the adult rat heart (2, 5). our evaluation 
of myocardial expression of protein p53 has been somewhat 
biased, as we have assumed that this protein exists primarily to 
regulate the cell cycle.
the potential role of tumor suppressor gene product 
expression in myocardial development and pathology 
is discussed by Kim and colleagues (16). these authors 
demonstrated that in isoproterenol-induced hypertrophy in 
mice they did not find significantly induced tumor suppressor 
gene transcription. But they noticed that the study utilized total 
heart preparations and also they did not study the expression 
of these proteins for a long period after induction of lVh. 
Recent observations have underscored the importance of p53 
in regulating cardiomyocyte cell cycle activity in response to 
expression of DnA tumor virus oncoproteins (22). the profound 
roles of p53 in DnA tumor virus-induced cardiomyocyte 
proliferation raised the possibility that this protein might also 
exert a cell cycle regulatory role in the adult heart. in this 
study we have shown by immunoblotting that the expression 
of protein p53 alters dramatically, but transiently during the 
development of pressure overload induced lVh in rats.
that lVh had indeed occurred in our model was 
demonstrated by a 70% increase in echo lVM-to-tl ratio in 
AAB rats compared with So control animals by 45 days after 
operation (fig. 1). Previous investigators demonstrated that 
fig. 3. Densitometric analysis of p53 protein in lV tissue.
(A) quantitative analysis of Western blotting experiments from cytoplasmic extracts from left ventricular tissue from 9-13 abdominal aortic banding [AAB] and 
9 sham operated [So] rats on 10th, 15th, 20th, 25th, 35th and 45th day after operation. 
(B) quantitative analysis of the ratio of nuclear p53 to total nuclear protein for each sample from the same left ventricular tissue that cytoplasmic extracts were 
taken is depicted. Data are means±SD, a - P<0.05 vs. 10 day AAB; b - P<0.05 vs. 15 day AAB; c - P<0.05 vs. 20 day AAB; d - P<0.05 vs. 25 day AAB; e - P<0.05 
vs. 35 day AAB; f - P<0.05 vs. 45 day AAB; # - P<0.05 vs. respective So.
(c) Actual heart weights are plotted vs. normalized nuclear p53 expression in abdominal aortic banded animals. Data were analyzed by logistic regression for 
9-13 animals in each day, r = -0.59, P<0.0001; n=60.
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pressure overload is initially characterized by the development 
of concentric lVh with compensated left ventricular 
contractile performance (11, 19). our results demonstrate that 
hypertrophy of the left ventricle within the whole period of 
45 days after AAB compensates to maintain baseline cardiac 
function. Despite the increased blood pressure in AAB rats, 
the lV%FS in AAB groups was not different from that in So 
groups, which is most likely due to the greater wall thickness 
of the AAB groups in the presence of similar lVeDD.
in our model the magnitude of the pressure overload was 
sufficient to produce significant LVH within 10 day time frame. 
however, we report a further increase of echo lVM on the 
15th day after AAB. interestingly, on 20th day after operation 
there was a short lasting regression in lVM, followed by a 
new progression on 25th and 35th days. Above all, one may 
ask whether our finding is simply an artifact. The significant 
correlation between echo-lVM-to-tl ratio and actual hW-to-
tl ratio as well as the consistence of echocardiographic findings 
with postmortem measurements exclude this possibility. 
therefore, by assessing the changes in left ventricular structure 
and function in rats in short intervals of time for a period of 45 
days we suppose that during the progression of compensated 
lVh there is a short-lasting regression of lVh, found on the 
20th day in this model. Our findings were comparable to those 
of hill et al. (13). they followed the development of cardiac 
hypertrophy in mice 5 weeks after thoracic aortic banding. on 
the other hand, Akers et al. (1) assessed the changes in rats but 
only in long intervals of time - on the 3, 10, 30, 60 days after 
banding. We assume that the other investigators (1, 6) have not 
encountered the short-lasting regression of lVh because of the 
long intervals of time at which they study the development of 
lVh.
our results suggest that protein p53 may take part in the 
hypertrophic growth, induced by pressure overload. We 
observed a fluctuation of the level of protein p53 in the nucleus 
of lV tissue during the development of lVh. the increased level 
of protein p53 in lV tissue was only seen during a relatively 
short period in the nucleus in our model of lVh. thus, the 
initial increase in p53 in lV tissue of AAB rats on 10th day was 
followed by a subsequent decrease of the expression on the 15th 
day such that levels were not significantly different from levels 
of So rats. Similar decrease of this protein was observed in 
the nucleus on the 25th day. it was interesting to note also that 
increased level of protein p53 in the nucleus was highest on the 
20th day when we observed a short lasting regression in lVh 
in our model. the exact reason for this observation remains 
unknown at this time, although a number of factors could be 
responsible. A possible explanation for the initial increase on 
the 10th day is that abdominal aortic banding might be a trauma 
that causes changes in neural and/or humoral factors and may 
induce subsequent changes in specific gene and/or protein 
expression in the heart.
We have shown that expression of protein p53 in the 
nucleus alters dramatically, but transiently, during the 
development of lVh in rats. the reason(s) why protein p53 
expression becomes upregulated on the 20th day after AAB 
or which factor(s) triggers the subsequent decrease in p53 in 
LV tissue five days after the period of upregulation during 
hypertrophy remains unknown at the present time. however, 
it is possible that the activity of certain cardiac p53-activating 
signals may be involved which can lead within a relatively 
short time to a marked elevation in p53 protein, or inactivation 
of the proteins that control its degradation (23). Furthermore, 
Wang et al. (28) detected increased expression of p53 induced 
by iGF i in the continuously proliferating h9c2 cells and in 
the primary cardiomyocytes that do not replicate one week 
after isolation. they suggest that protein p53 is involved in 
one of the fundamental signaling machinery in cardiac muscle 
cells. According to Anversa et al. (2) adult cardiomyocytes 
are not terminally differentiated. in light of these hypotheses, 
a possible explanation of our finding is that adult ventricular 
myocytes, under the certain circumstances during the 
development of lVh, appear to re-enter the cell cycle and 
proliferate (7). the short-lasting regression of lVh on 20th 
day in our model may be a result of the small size of the new 
cardiomyocytes immediately after the mitosis. in this aspect the 
increased expression of protein p53 in the nucleus on this day is 
explicable as a cell cycle checkpoint determinant. Protein p53 
is a critical component of an inhibitory pathway that negatively 
regulates progression of the cell cycle. the inhibitory pathway 
mediated by p53 prevents the cells from entering S phase and 
thus may divert the cells toward differentiation or apoptosis 
pathways (8).
conclusions
the observation of the increased expression of p53 protein 
and its correlation with the short lasting regression during the 
development of lVh suggests that p53 protein may modulate 
the adaptive growth of pressure overload induced lVh. it may 
also provide us with an opportunity to understand more clearly 
the mechanisms of this process and may eventually lead to 
successful strategies for the treatment of this process.
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